UNSPSC 51102861: Methylprednisolone/neomycin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE250. This VA Drug Class (DE250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL.

UNSPSC 51102861 Methylprednisolone/neomycin is a Commodity code nominally covering specific pharmaceutical products, but recent state and local solicitations tagged under it reflect a much broader procurement landscape encompassing emergency medical supplies, naloxone, and generic pharmaceuticals through cooperative purchasing vehicles. The scope of work being solicited includes finished medical and first aid supplies (respiratory equipment, cardiac monitoring electrodes, airway devices, bandaging materials, oxygen delivery systems) procured by fire and rescue divisions; naloxone and drug deactivation systems for community health programs; and generic multi-source pharmaceuticals and over-the-counter products distributed across state and local government facilities. Issuing bodies include county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health and human services commissions (Texas HHS Commission), and cooperative purchasing alliances serving multiple jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, which includes Oregon participation). The Minnesota cooperative appears as a repeat buyer, managing statewide pharmaceutical contracts for multiple states and local entities.

Recent activity concentrates in Florida, Texas, and Minnesota. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) soliciting 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's ITB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a 5% bid discount for certified Small Local Business Enterprises; MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) establishing multiple contracts for generic pharmaceuticals and OTC products across participating state and local facilities; and the Texas HHS Commission's Request for Information HHS0017013 (posted April 3, 2026, due April 3, 2026) gathering vendor intelligence on direct-to-manufacturer prescription programs. The Tampa procurement explicitly shelters bids for certified SLBEs, while MMCAP contracts require compliance with current Good Manufacturing Practices, Drug Supply Chain Security Act certification, and maintain authorized-wholesaler distribution channels.